ACU
Bearish signalScored 2026-08-13 Drivers: fundamentals. Moteurs : fondamentaux.
Research, not advice.
À propos
Acme United Corporation
- Nom
- Acme United Corporation
- Secteur
- Consumer Defensive
- Industrie
- Household & Personal Products
- Bourse
- AMEX
- Capitalisation
- $243.4M
- Employés
- 649
- PDG
- Walter C. Johnsen
- Site web
- https://www.acmeunited.com
- Marché
- ACCOHLMNNPKNWL
Acme United Corporation is a global supplier specializing in first aid, safety, cutting, sharpening, and measuring tools. Its products cater to a diverse clientele across educational institutions, households, corporate offices, hardware stores, sporting goods outlets, and industrial sectors throughout the United States, Canada, Europe, and other international markets. The company's extensive portfolio is distributed under several prominent brands. Westcott offers a broad array of items including scissors, shears, various knives, rulers, pencil sharpeners, paper trimmers, specialized safety cutters, lettering supplies, glue guns, and craft essentials. Cutting implements fall under the Clauss brand. For outdoor and tactical applications, Camillus features fixed-blade and folding knives, sight-cutting devices, and tactical tools. Anglers benefit from Cuda, which provides fishing tools and knives, protective cut- and puncture-resistant gloves, telescopic landing nets, net containment systems, and fishing gaffs. Precision sharpening solutions are supplied by DMT. In the health and safety segment, First Aid Only delivers comprehensive first aid kits and safety provisions. PhysiciansCare offers portable eyewash solutions and a range of over-the-counter medications, including aspirin, acetaminophen, and ibuprofen. Spill Magic addresses bodily fluid and general spill clean-up requirements. First Aid Central expands the first aid offerings with various kits, refills, and specialized safety supplies like CPR, burn, automotive, and emergency kits. Lastly, Med-Nap provides a selection of sanitary wipes, such as alcohol prep pads, alcohol wipes, benzalkonium chloride wipes, antiseptic wipes, castile soaps, and lens cleaning wipes. Acme United employs a multi-channel distribution strategy, selling directly and through independent manufacturer representatives to a vast network. This includes wholesale, contract, and retail stationery distributors, large office supply stores, school supply channels, industrial distributors, wholesale florists, mass market and e-commerce retailers, and hardware chains. A curated range of its products is also available for purchase on the company's official websites. Founded in 1867 as Acme Shear Company, the corporation was renamed Acme United Corporation in 1971 and is headquartered in Shelton, Connecticut.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 25 722 titres (~1 504 110,35 $ US)
- Insiders
- OLSCHAN BRIAN SBARKER BRIANDavidson Rex Lynn
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$1,280,709
Avg sell (VWAP, 90d window) $58.05 vs last close —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- 2026-08-18
- Last synced
-
2026-08-25 17:08:49
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-10-09 | HOLDEN RICHMOND Y JR | Sell · S | 341 | $62.01 | $21,145 | Form 4 |
| 2026-08-18 | OLSCHAN BRIAN S | Sell · S | 3,308 | $61.63 | $203,872 | Form 4 |
| 2026-08-13 | BARKER BRIAN | Sell · S | 3,821 | $60.50 | $231,170 | Form 4 |
| 2026-08-12 | OLSCHAN BRIAN S | Sell · S | 339 | $58.39 | $19,794 | Form 4 |
| 2026-08-11 | OLSCHAN BRIAN S | Sell · S | 159 | $57.99 | $9,220 | Form 4 |
| 2026-08-10 | OLSCHAN BRIAN S | Sell · S | 5,304 | $57.07 | $302,699 | Form 4 |
| 2026-08-10 | Davidson Rex Lynn | Sell · S | 3,684 | $56.48 | $208,072 | Form 4 |
| 2026-08-07 | OLSCHAN BRIAN S | Sell · S | 125 | $55.72 | $6,965 | Form 4 |
| 2026-08-05 | OLSCHAN BRIAN S | Sell · S | 4,000 | $55.51 | $222,040 | Form 4 |
| 2026-08-04 | OLSCHAN BRIAN S | Sell · S | 981 | $56.75 | $55,672 | Form 4 |
| 2026-08-03 | OLSCHAN BRIAN S | Sell · S | 1 | $58.00 | $58 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Signal
Bearish signalScored 2026-08-13 Drivers: fundamentals. Moteurs : fondamentaux.
ACU delivered a substantial Q2 2026 earnings beat ($1.22 vs $0.48 est.) alongside 16% net sales growth and a new $65M credit facility, providing a credible near-term catalyst supported by strong liquidity (current ratio…
The first sentence of the analysis written for ACU on 2026-08-13 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Narrative Supports a bullish reading. Stored narrative reading is in the bullish band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Supports a bullish reading. Current ratio 4.21 · operating margin 7.5%
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 39.4% | 39.3% | 37.7% | 32.8% | 35.6% | |
| Ebit Margin | 7.5% | 7.4% | 13.5% | 3.1% | 8.8% | |
| Ebitda Margin | 10.8% | 10.5% | 16.1% | 5.5% | 11.2% | |
| Operating Profit Margin | 7.5% | 7.3% | 6.9% | 3.2% | 7.0% | |
| Pretax Profit Margin | 6.7% | 6.3% | 11.9% | 1.9% | 8.3% | |
| Continuous Operations Profit Margin | 5.2% | 5.2% | 9.3% | 1.6% | 7.5% | |
| Net Profit Margin | 5.2% | 5.2% | 9.3% | 1.6% | 7.5% | |
| Bottom Line Profit Margin | 5.2% | 5.2% | 9.3% | 1.6% | 7.5% | |
| Current Ratio | 4.206 | 4.174 | 3.538 | 4.773 | 4.698 | |
| Quick Ratio | 1.589 | 1.714 | 1.405 | 1.911 | 2.057 | |
| Solvency Ratio | 0.310 | 0.292 | 0.445 | 0.089 | 0.265 | |
| Cash Ratio | 0.157 | 0.280 | 0.184 | 0.276 | 0.239 | |
| Price To Earnings Ratio | 14.985 | 13.775 | 8.819 | 25.465 | 8.575 | |
| Price To Earnings Growth Ratio | -20.305 | -0.311 | 0.019 | -0.326 | 0.137 | |
| Forward Price To Earnings Growth Ratio | -20.305 | -0.311 | 0.019 | -0.326 | 0.137 | |
| Price To Earnings Diluted Ratio | 16.189 | 15.237 | 8.819 | 26.707 | 9.768 | |
| Price To Earnings Diluted Growth Ratio | 9.916 | -0.307 | 0.018 | -0.350 | 0.198 | |
| Price To Book Ratio | 1.298 | 1.291 | 1.601 | 0.978 | 1.518 | |
| Price To Sales Ratio | 0.777 | 0.710 | 0.819 | 0.398 | 0.642 | |
| Price To Free Cash Flow Ratio | 20.146 | 28.621 | 6.553 | -45.112 | -94.953 | |
| Price To Operating Cash Flow Ratio | 8.374 | 11.536 | 5.425 | 26.716 | 22.757 | |
| Debt To Assets Ratio | 0.165 | 0.203 | 0.171 | 0.386 | 0.329 | |
| Debt To Equity Ratio | 0.240 | 0.307 | 0.261 | 0.803 | 0.616 | |
| Debt To Capital Ratio | 0.194 | 0.235 | 0.207 | 0.445 | 0.381 | |
| Long Term Debt To Capital Ratio | 0.153 | 0.204 | 0.193 | 0.434 | 0.364 | |
| Financial Leverage Ratio | 1.454 | 1.516 | 1.524 | 2.080 | 1.874 | |
| Working Capital Turnover Ratio | 2.694 | 2.806 | 2.562 | 2.448 | 2.630 | |
| Operating Cash Flow Ratio | 0.797 | 0.524 | 1.111 | 0.131 | 0.254 | |
| Operating Cash Flow Sales Ratio | 0.093 | 0.062 | 0.151 | 0.015 | 0.028 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.416 | 0.403 | 0.828 | -0.592 | -0.240 | |
| Debt Service Coverage Ratio | 10.823 | 7.211 | 8.383 | 4.159 | 20.374 | |
| Interest Coverage Ratio | 8.750 | 6.787 | 4.259 | 2.618 | 13.850 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 27.406 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.645 | 0.365 | 1.133 | 0.046 | 0.108 | |
| Capital Expenditure Coverage Ratio | 1.711 | 1.675 | 5.808 | 0.628 | 0.807 | |
| Dividend Paid And Capex Coverage Ratio | 1.403 | 1.278 | 4.147 | 0.444 | 0.630 | |
| Dividend Payout Ratio | 0.230 | 0.222 | 0.112 | 0.627 | 0.131 | |
| Enterprise Value Multiple | 8.385 | 8.050 | 5.744 | 12.703 | 7.862 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 39.4% | ▲0.1% | ▲2.4% |
| Ebit Margin | 7.5% | ▲0.1% | ▼-0.5% |
| Ebitda Margin | 10.8% | ▲0.2% | ▼-0.0% |
| Operating Profit Margin | 7.5% | ▲0.2% | ▲1.1% |
| Pretax Profit Margin | 6.7% | ▲0.4% | ▼-0.3% |
| Continuous Operations Profit Margin | 5.2% | ▲0.0% | ▼-0.6% |
| Net Profit Margin | 5.2% | ▲0.0% | ▼-0.6% |
| Bottom Line Profit Margin | 5.2% | ▲0.0% | ▼-0.6% |
| Current Ratio | 4.206 | ▲0.032 | ▼-0.072 |
| Quick Ratio | 1.589 | ▼-0.125 | ▼-0.146 |
| Solvency Ratio | 0.310 | ▲0.018 | ▲0.030 |
| Cash Ratio | 0.157 | ▼-0.122 | ▼-0.070 |
| Price To Earnings Ratio | 14.985 | ▲1.210 | ▲0.661 |
| Price To Earnings Growth Ratio | -20.305 | ▼-19.994 | ▼-16.148 |
| Forward Price To Earnings Growth Ratio | -20.305 | ▼-19.994 | ▼-16.148 |
| Price To Earnings Diluted Ratio | 16.189 | ▲0.952 | ▲0.845 |
| Price To Earnings Diluted Growth Ratio | 9.916 | ▲10.223 | ▲8.021 |
| Price To Book Ratio | 1.298 | ▲0.007 | ▼-0.039 |
| Price To Sales Ratio | 0.777 | ▲0.066 | ▲0.107 |
| Price To Free Cash Flow Ratio | 20.146 | ▼-8.476 | ▲37.095 |
| Price To Operating Cash Flow Ratio | 8.374 | ▼-3.162 | ▼-6.587 |
| Debt To Assets Ratio | 0.165 | ▼-0.037 | ▼-0.085 |
| Debt To Equity Ratio | 0.240 | ▼-0.067 | ▼-0.205 |
| Debt To Capital Ratio | 0.194 | ▼-0.041 | ▼-0.099 |
| Long Term Debt To Capital Ratio | 0.153 | ▼-0.051 | ▼-0.117 |
| Financial Leverage Ratio | 1.454 | ▼-0.062 | ▼-0.236 |
| Working Capital Turnover Ratio | 2.694 | ▼-0.113 | ▲0.066 |
| Operating Cash Flow Ratio | 0.797 | ▲0.273 | ▲0.234 |
| Operating Cash Flow Sales Ratio | 0.093 | ▲0.031 | ▲0.023 |
| Free Cash Flow Operating Cash Flow Ratio | 0.416 | ▲0.013 | ▲0.253 |
| Debt Service Coverage Ratio | 10.823 | ▲3.612 | ▲0.633 |
| Interest Coverage Ratio | 8.750 | ▲1.962 | ▲1.497 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | ▼-27.407 | ▼-5.481 |
| Operating Cash Flow Coverage Ratio | 0.645 | ▲0.280 | ▲0.186 |
| Capital Expenditure Coverage Ratio | 1.711 | ▲0.036 | ▼-0.415 |
| Dividend Paid And Capex Coverage Ratio | 1.403 | ▲0.125 | ▼-0.178 |
| Dividend Payout Ratio | 0.230 | ▲0.008 | ▼-0.034 |
| Enterprise Value Multiple | 8.385 | ▲0.335 | ▼-0.164 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $152.7M | $138.1M | $156.8M | $77.3M | $117.0M | |
| Enterprise value | $177.3M | $164.6M | $177.5M | $134.6M | $159.6M | |
| EV / Sales | 0.90x | 0.85x | 0.93x | 0.69x | 0.88x | |
| EV / Op. cash flow | 9.73x | 13.74x | 6.14x | 46.54x | 31.05x | |
| EV / Free cash flow | 23.40x | 34.10x | 7.42x | -78.58x | -129.56x | |
| EV / EBITDA | 8.38x | 8.05x | 5.74x | 12.70x | 7.86x | |
| Net debt / EBITDA | 1.17x | 1.29x | 0.67x | 5.41x | 2.10x | |
| Current ratio | 4.21x | 4.17x | 3.54x | 4.77x | 4.70x | |
| Income quality | 1.79x | 1.20x | 1.62x | 0.95x | 0.38x | |
| Graham number | $43 | $42 | $54 | $21 | $44 | |
| Graham net-net | $1 | $0 | $0 | -$7 | -$3 | |
| Tax burden | 77.6% | 81.5% | 78.3% | 82.8% | 90.0% | |
| Interest burden | 88.6% | 85.5% | 88.0% | 60.5% | 94.3% | |
| Working capital | $73.3M | $72.6M | $66.0M | $83.5M | $75.0M | |
| Invested capital | $148.1M | $139.3M | $123.2M | $141.5M | $124.2M | |
| Return on assets | 6.0% | 6.2% | 11.9% | 1.8% | 9.5% | |
| Operating ROA | 8.8% | 9.1% | 8.4% | 4.1% | 9.3% | |
| Return on tangible assets | 7.2% | 7.6% | 14.6% | 2.2% | 11.2% | |
| Return on equity | 8.7% | 9.4% | 18.2% | 3.8% | 17.7% | |
| Return on invested capital | 7.6% | 8.2% | 8.3% | 3.6% | 9.2% | |
| Return on capital employed | 9.9% | 10.2% | 10.7% | 4.4% | 10.3% | |
| Earnings yield | 6.7% | 7.3% | 11.3% | 3.9% | 11.7% | |
| Free cash flow yield | 5.0% | 3.5% | 15.3% | -2.2% | -1.1% | |
| Capex / Op. cash flow | 58.4% | 59.7% | 17.2% | 159.2% | 124.0% | |
| Capex / Depreciation | 167.8% | 117.8% | 98.2% | 100.6% | 157.4% | |
| Capex / Sales | 5.4% | 3.7% | 2.6% | 2.4% | 3.5% | |
| SG&A / Sales | 31.9% | 32.0% | 30.8% | 29.5% | 28.6% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 1.0% | 1.1% | 1.0% | 0.9% | 1.0% | |
| Intangibles / Total assets | 17.2% | 18.6% | 18.2% | 17.6% | 15.3% | |
| Days sales outstanding | 54d | 53d | 50d | 61d | 69d | |
| Days payables outstanding | 25d | 28d | 37d | 29d | 28d | |
| Operating cycle | 237d | 227d | 220d | 239d | 235d | |
| Cash conversion cycle | 213d | 199d | 183d | 209d | 207d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-08-14 Acme United (ACU) is an Incredible Growth Stock: 3 Reasons Why Acme United (ACU) possesses solid growth attributes, which could help it handily outperform the market.
- 2026-07-23 Acme United Corporation (ACU) Q2 2026 Earnings Call Transcript Acme United Corporation (ACU) Q2 2026 Earnings Call Transcript
- 2026-07-23 Acme United Corporation. (ACU) Q2 Earnings and Revenues Beat Estimates Acme United Corporation. (ACU) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $0.48 per share.
- 2026-07-23 Acme United Reports Second Quarter 2026 Net Sales Increase of 16% and Net Income Increase of 6% SHELTON, Conn., July 23, 2026 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended June 30, 2026 were $62.7 million compared to $54.0 million for the quarter ended June 30, 2025, an increase of 16%. Excluding sales resulting from the acquisition of the assets of My Medic on January 15, 2026, comparable three-month sales increased 8%. Net sales for the six months ended June 30, 2026 were $115.0 million, compared to $100.0 million in the same period in 2025, an increase of 15%. Excluding My Medic sales, comparable six-month sales increased 7%.
- 2026-07-17 Dividend Champion, Contender, And Challenger Highlights: Week Of July 19 A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies that changed their dividends. Companies with upcoming ex-dividend dates.
- 2026-07-15 Acme United Corporation Announces New Bank Facility SHELTON, Conn., July 15, 2026 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) today announced it has entered into a new $65 million syndicated credit facility with HSBC Bank USA, N.A. (HSBC) and City National Bank (CNB), a U.S. subsidiary of Royal Bank of Canada (RBC).
- 2026-07-15 Acme United to Release Second Quarter 2026 Financial Results on July 23, 2026 SHELTON, Conn., July 15, 2026 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) will release its financial results for the second quarter of 2026 on Thursday, July 23, 2026, at 6:30 AM Eastern Time.
- 2026-06-17 Acme United Corporation Board Approves Cash Dividend SHELTON, Conn., June 17, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Acme United Corporation (NYSE American: ACU) declared a cash dividend of 16 cents per share on its outstanding common stock. The dividend is payable on July 23, 2026, to stockholders of record on the close of business on July 2, 2026.